Advanced Medical Isotope SG&A Expenses 2013-2025 | RDGL

Advanced Medical Isotope sg&a expenses from 2013 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Advanced Medical Isotope SG&A Expenses 2013-2025 | RDGL

Advanced Medical Isotope sg&a expenses from 2013 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company NameMarket
Cap
Ares Capital (ARCC)$16.1B
Blackstone Secured Lending Fund (BXSL)$7.4B
Blue Owl Technology Finance (OTF)$7.3B
Main Street Capital (MAIN)$5.7B
Golub Capital BDC (GBDC)$4.1B
Hercules Capital (HTGC)$3.4B
Sixth Street Specialty Lending (TSLX)$2.3B
Morgan Stanley Direct Lending Fund (MSDL)$1.7B
Goldman Sachs BDC (GSBD)$1.4B
New Mountain Finance (NMFC)$1.2B
Kayne Anderson BDC (KBDC)$1.1B
BARINGS BDC, INC (BBDC)$1B
Amalgamated Financial (AMAL)$1B
Bain Capital Specialty Finance (BCSF)$1B
Trinity Capital (TRIN)$968M
Nuveen Churchill Direct Lending (NCDL)$856M
Fidus Investment (FDUS)$759M
Carlyle Secured Lending (CGBD)$712M
BLACKROCK TCP CAPITAL CORP (TCPC)$654M
Gladstone Capital (GLAD)$645M
CION Investment (CION)$531M
Gladstone Investment (GAIN)$519M
PennantPark Investment (PNNT)$475M
Palmer Square Capital BDC (PSBD)$456M
Stellus Capital Investment (SCM)$424M
Runway Growth Finance (RWAY)$417M
Saratoga Investment Corp (SAR)$394M
Horizon Technology Finance (HRZN)$325M
TriplePoint Venture Growth BDC (TPVG)$290M
Chicago Atlantic BDC (LIEN)$237M